Telesis Bio, Inc. (TBIO) Q2 2023 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and thank you for standing by. Welcome to the Q2 2023 Telesesis BioEarnings Conference Call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1-1 on your telephone. You will hear an automated message advising your hand is raised. To withdraw your question, please press star 1-1 again. Please be advised today's conference is being recorded. I would now like to turn the conference over to your speaker today, Jen Carroll, Vice President, Investor Relations. Thank you, and thank you for joining us for Telesys Bio's second quarter 2023 earnings call. With me on the call today are Telesys Bio founder and Chief Executive Officer, Todd Nelson, and our President and Chief Operating Officer, Eric Esser. Our second quarter 2023 financial results press release is now available on the Investor section of our website. Before we begin, I would like to inform you that certain statements we make during the call will be forward-looking statements that involve known and unknown risks and uncertainties that may cause actual results to differ materially from those expressed or implied. Such factors include those referenced in the Safe Harbor Statement included in our earnings release and in our filings with the FCC. This conference call contains time-sensitive information and is accurate only as of the live broadcast on August 10, 2023. Finally, any percentage changes we discuss will be on a year-over-year basis unless otherwise noted. And with that, I will hand the call over to our CEO, Todd Nelson, and we can get started. Thanks, Jen. Welcome, everyone, and thanks for joining today's call home. We're pleased with the progress t...